Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness in older adults. In its advanced form, known as wet AMD, abnormal blood vessels develop in the macula—the central part of the retina responsible for sharp, detailed vision. These fragile blood vessels are prone to leaking fluid and blood, leading to macular damage and impaired vision. While wet AMD accounts for a smaller portion of all AMD cases, it is responsible for 90% of AMD-related blindness.
In the early stages, wet AMD can be managed with medications that slow the growth of these abnormal blood vessels. However, as the disease progresses, these treatments become less effective. Now, a new study led by Yong Liu and colleagues at Third Military Medical University Southwest Hospital in China, published on February 27 in Stem Cell Reports, suggests an innovative alternative for advanced wet AMD cases. The research proposes surgically removing the abnormal blood vessels and transplanting stem cell-derived retinal cells to replace damaged tissue, offering renewed hope for improving outcomes in more severe cases.
Continue reading… “A Promising Stem Cell Approach for Advanced Wet AMD Treatment”